| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.32 | 9e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.33 | 1e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.32 | 2e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.09 |